FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stent, Superficial Femoral Artery, Drug-Eluting

PMA: P180011 · Supplement: S060 · Decision Jan 30, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P180011 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Stent, Superficial Femoral Artery, Drug-Eluting
Trade Name
Eluvia Drug-Eluting Vascular Stent System
PMA Number
P180011
Supplement Number
S060
Device Class
FDA Class 3
Product Code
NIU
Generic Name
Stent, superficial femoral artery, drug-eluting
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
January 30, 2026
Date Received
June 20, 2024
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Labeling Change - PAS
Expedited Review
N

Advisory Committee Statement

Approval for the post-approval labeling update to reflect the findings of the EMINENT post-approval study.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIU Stent, Superficial Femoral Artery, Drug-Eluting